slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 74,971-75,000
Pages 3,679
Rows per page 30
Component
74,971-75,000 of 110,355
11
Includes footnotes regarding stock-based compensation.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · SatisfactionLoop · Why Now1 hit
14
The table provides a standard financial reconciliation format.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Action1 hit
15
Includes a footnote regarding regulatory and legal matters.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Action1 hit
10
The table highlights the clinical gap in patients with prior kinase inhibitor treatment, specifically those with G2032R mutations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
12
The slide uses a medical illustration to map specific TRK receptor inhibition side effects to anatomical locations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
The slide uses dot plots for IC50 values and a bar chart for tumor regression, highlighting NVL-520's performance.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
14
The slide uses a bar chart to show brain penetrance and a grouped bar chart to show selectivity index, highlighting the drug's potential to avoid off-target CNS effects.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
15
The slide uses a side-by-side comparison layout to distinguish between the dose escalation (Phase 1) and the registrational intent (Phase 2) study designs.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
16
The slide details the transition from the all-treated population to the NSCLC response-evaluable population.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
17
The table highlights a heavily pretreated population, with 77% having received 3 or more prior lines of therapy and 71% having received 2 or more prior ROS1 TKIs.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
18
Data as of 13 Sep 22. N=35 patients.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
24
Includes specific patient case study (65-year-old female) and aggregate clinical trial data.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
28
Includes detailed clinical trial design, cohort definitions, and study objectives.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
30
The slide uses a structured table to segment the patient population based on treatment history and specific genetic mutations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
32
Shows superior potency and efficacy against resistant mutations compared to standard-of-care inhibitors like Lorlatinib.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
34
Clinical trial design slide detailing patient population, objectives, and cohort structure.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
35
BOIN stands for Bayesian Optimal Interval design.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
36
Clinical trial baseline characteristics table.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
38
The chart displays a line graph with error bars representing standard deviation for five different dosage cohorts (15mg to 150mg QD).Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
43
The slide presents two patient case studies with MRI scans showing tumor reduction.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
44
Includes clinical data points for EML4-ALK v3, G1202R, G1269A, and I1322M.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
45
The slide summarizes clinical trial conclusions for a pharmaceutical asset.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
50
The slide uses a Gantt-chart style visualization to show the progress of three specific drug candidates (NVL-520, NVL-655, NVL-330) through clinical development phases.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
06
The slide uses a callout to emphasize sequential improvement in Adj. EBITDA.Oatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
09
The slide uses two distinct bar charts to highlight performance metrics in the EMEA region for Q3 2023.Oatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
10
Includes a callout box highlighting consistent mid-single digit growth in established markets.Oatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
14
Oatly | Results Presentation Deck | 39 slidesOatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
15
Oatly | Results Presentation Deck | 39 slidesOatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations 1 hit
16
Includes logos for Meijer, Costco, Walmart, and Stop & Shop.Oatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations 1 hit
17
The slide uses product imagery to illustrate brand expansion.Oatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations 1 hit